NCT06595043 Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation
| NCT ID | NCT06595043 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University, China |
| Condition | The Direction of Blocker Placement |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2024-10-09 |
| Primary Completion | 2025-10-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2024-10-09 with a primary completion date of 2025-10-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial is a practical, multicenter, prospective, parallel grouping, randomized controlled,two-arm study. This study will be conducted in three centers including the First Hospital of China Medical University, Seoul National University Hospital and the University Clinical Center of Serbia. The investigators aim to investigate the effect of different occlusion angles of disposable tracheal blocker on right one-lung ventilation
Eligibility Criteria
Inclusion Criteria: * Age ranged from 18 to 65 years old; * American Society of Anesthesiologists (ASA) grade I-III; * No history of drug allergy or abnormal anesthesia; * Patients undergoing right thoracoscopic surgery; * The preoperative oxygen saturation was not less than 94%. Exclusion Criteria: * Patients with a history of acute lung injury or ARDS within 3 months; * Cardiac function class IV (New York Heart Association classification); * Chronic renal failure (renal cell filtration rate \<30ml min-11.73m-2), severe liver disease; * Patients with blurred consciousness and cognitive dysfunction; * Patients with severe coagulation dysfunction; * Without preoperative oxygen inhalation, blood oxygen \<94%, severe pulmonary dysfunction; * Patients with endotracheal tube admitted to ICU after operation; * Body mass index (BMI) \>30; * Patients who had had lung surgery； * Inability to complete the study;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06595043 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying The Direction of Blocker Placement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06595043 currently recruiting?
Yes, NCT06595043 is actively recruiting participants. Contact the research team at wftan@cmu.edu.cn for enrollment information.
Where is the NCT06595043 trial being conducted?
This trial is being conducted at Shenyang, China, Belgrade, Serbia, Seoul, South Korea.
Who is sponsoring the NCT06595043 clinical trial?
NCT06595043 is sponsored by China Medical University, China. The trial plans to enroll 96 participants.